ACG 2023 Conference Coverage
Playback speed
10 seconds
ACG 2023 Highlights: Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis at 8-16 Weeks: A Multicenter Retrospective Cohort Study
By
ACG 2023 Conference Coverage
FEATURING
Rahul Dalal
By
ACG 2023 Conference Coverage
FEATURING
Rahul Dalal
50 views
October 30, 2023
Comments 0
Login to view comments.
Click here to Login
Videos